Psoriasis is a chronic skin disorder causing red, scaly plaques, affecting various body parts, with varying severity levels.

Psoriasis is a chronic disease caused by an overactive immune system associated with inflammation throughout the body. Symptoms tend to resolve and reoccur throughout a person’s life. It is estimated ...

Psoriasis is a chronic immune-mediated inflammatory disease, meaning inflammation plays a key role in its development. While its exact cause remains unknown, psoriasis affects up to 3% of adults ...

“Defining on-treatment remission in plaque psoriasis represents a meaningful step forward for the field,” April W. Armstrong, MD, MPH, University of California, Los Angeles, and coauthors wrote.

(RTTNews) - Drug major Johnson & Johnson (JNJ) on Tursday announced positive Icotrokinra results, which showed that 75% of adolescents with plaque psoriasis or PsO achieved completely clear skin ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque psoriasis, with one producing a PASI90 response in 61% of patients at 52 weeks.